Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Brianna Castillo"'
Autor:
Andrea Gilmore, MD, Brianna Castillo, MD, Nicholas Golda, MD, Kara Braudis, MD, Emily Smith, MD
Publikováno v:
JAAD International, Vol 15, Iss , Pp 100-104 (2024)
Background: Mohs micrographic surgery (MMS) is used for the treatment of high-risk cutaneous squamous cell carcinoma (cSCC). MMS examines the surgical margins in real time and does not commonly examine the central component of the tumor. Objective: T
Externí odkaz:
https://doaj.org/article/edfd386fde4a4d07a7604f755cabe3d4
Publikováno v:
The American Journal of Dermatopathology. 45:64-68
Ponatinib is a third-generation tyrosine kinase inhibitor used to treat chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia. Cutaneous toxicities are a commonly reported side effect of ponatinib treatment with "rash" being
Publikováno v:
Journal of the American Academy of Dermatology.
Autor:
Brianna Castillo, Emily Smith
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB173
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB174
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB176
Publikováno v:
JAAD Case Reports
Under physiologic conditions, immune checkpoints provide negative signals to control T-cell activation and prevent inflammation-associated tissue destruction. Cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4), a principal negative regulator of T
Publikováno v:
Int Wound J
Publikováno v:
Journal of the American Academy of Dermatology. 79(4)
Autor:
Paul D. Smith, Zhenjun Ma, Ambuj Kumar, Amina Lleshi, Joshua B. Elston, Sangeetha Prabhakaran, Weihong Sun, Brianna Castillo, Deniz Dayicioglu
Publikováno v:
Annals of plastic surgery. 78(6S Suppl 5)
Background Patients with a history of prior breast augmentation and newly diagnosed breast cancer represent a rapidly expanding and unique subset of patients. Prior studies have described changes in breast parenchyma and characteristic body habitus o